We're excited to announce additional funding for gene editing research
CF Foundation Provides Additional Funding to Advance ReCode Therapeutics’ Gene Delivery Technology
|
We're providing additional funding to ReCode Therapeutics to further develop the company’s delivery method to carry a potential gene editing therapy to the lungs of people with cystic fibrosis.
|
|
| |
|
Register for Virtual Access to Select North American Cystic Fibrosis Conference (NACFC) Sessions
|
Join us online Oct. 8-10 to hear the latest advancements in cystic fibrosis research and care. Tune in for three plenaries and six sessions selected by members of the CF community — covering topics ranging from gene editing and CFTR modulators to liver disease and aging. All sessions will be available with live Spanish interpretation.
|
|
| |
|
Connect With Others About Life Without Modulators
|
Not everyone can benefit from CFTR modulators like Alyftrek, Trikafta, Symdeko, Kalydeco, or Orkambi — and that can feel isolating. If you or your loved one cannot benefit from these therapies, join a virtual, small-group discussion Aug. 18 at 7 p.m. ET. Connect with others who understand your experience and find support in an open, welcoming space.
|
|
| |
|
Level Up Your Fundraising
|
Looking for inspiration for your next fundraiser? Or ready to take your existing fundraiser to the next level? Join fellow volunteers Aug. 19 at 7 p.m. ET for an interactive webinar where you can exchange ideas, learn practical tips, and explore new ways to make a difference for the cystic fibrosis community.
|
|
| |
|
4550 Montgomery Avenue, Suite 1100N | Bethesda, MD 20814 US
|
|
|
|
|
